Intravenous methylprednisolone versus intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy: an randomized trial
Journal Title: International Journal of Medical Research and Review - Year 2016, Vol 4, Issue 7
Abstract
Introduction: Corticosteroids and Intravenous immunoglobulin (IVIg) are effective as initial treatment in patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), but their long-term use is less defined. We compared the efficacy and tolerability of 6-month therapy of intravenous methylprednisolone (IV MP) versus IVIg. Methods: This trial compared efficacy and tolerability of IVIg (0·5g/kg per day for 4 consecutive days) and IV MP (0·5 g in 250 ml sodium chloride solution per day for 4 consecutive days) given every month for 6 months were assessed. After therapy discontinuation, patients were followed up for 6 months to assess relapses. Results: 40 patients (20 IV MP, 20 IVIg) completed the study. More patients stopped MP (12 [60%] of 20) than IVIg (8 [40%] of 20; relative risk 0·54, 95% CI 0·34–0·87; p=0·0085). When adjusted for sex, age, disease duration, comorbidity, modified Rankin scale (mRS) at enrolment, and previous treatment with IVIg and steroids, the difference between the two groups remained significant (odds ratio 7·6, 95% CI 1·7–33·8; p=0·0070). Reasons for discontinuation were lack of efficacy (twelve in the IV MP group vs. 8 in the IVIg group), adverse events (one in the IV MP group), or voluntary withdrawal (2 in IV MP group). The proportion of patients with adverse events did not differ between IV MP group (14 [67%] of 20) and IVIg group (11 [46%] of 20; p=0·1606). After discontinuation, more patients on IVIg worsened and required further therapy (eight [38%] of 20, p=0·0316). Conclusion: Treatment of CIDP with IVIg for 6 months was less frequently discontinued than with IV MP.
Authors and Affiliations
Priyanka V Kashyap, Sunil Jee Bhat
Keywords
Related Articles
- EP ID EP230604
- DOI 10.17511
- Views 112
- Downloads 0
Cardiogenic shock in Non-ST elevated AMI patients in a rural tertiary care hospital in Eastern India
Introduction:Acute Myocardial infarction is one of the leading causes of morbidity and mortality worldwide. Cardiogenic Shock is the leading cause of death in patients hospitalised for acute MI. Although there is substan...
Microbiological flora of cell phones: a reservoir of potential pathogens?
Background: Hospital associated infections are a major problem in all hospital settings. The heavy use of cell phones which come in close contact with the body surfaces could act as a fomite for microorganisms and it can...
Comparison of midazolam versus clonazepam as premedication scheduled for elective abdominal hysterectomies
Background and aim: Anxiety is one of the most common problem which affect the patient during surgical procedures. Thus, anxiolytics have a primary role as premedication preoperatively. With this background, we designed...
Quality of life in arthritis patients and its correlation with anxiety and depression
Background: Although the medical and economic consequences of arthritis are of great concern to researchers and clinicians, this disease also affects an individual’s capacity to live a full and active life. Aim: To study...
Laboratory surveillance of H1N1 swine influenza A virus infection in patients with severe acute respiratory illness (SARI)-an institutional study
Introduction: Lower respiratory tract infections (LRTI) are a leading cause of death in developing countries and are also third leading cause of death worldwide. Influenza is an acute viral and highly contagious respirat...